UPC_CFI_774/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Procedural & sub-applicationsCosts AssessmentsMilan CDGenericCase Closed

Overview Decisions Documents Timeline

Parties

Claimants

Insulet Corporation

Reps: Marc Grunwald; Frank Peterreins

Respondents

EOFLOW Co., Ltd.

Reps: Mirko Weinert; Christopher Pierce

Judges

Andrea Postiglione
Anna-Lena Klein
Uwe Schwengelbeck

Patents

EP4201327

CPC codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291…

Sector: Packaging & Conveying

Outcome

Costs only

Filed: Aug 21, 2025

First decided: Oct 15, 2025

Language: English

The Central Division Milan decided a cost application in the Insulet v. EOFLOW proceedings, ruling that costs incurred after publication of the merits decision and enforcement costs fall outside the scope of R. 151 RoP and are not recoverable in the cost decision.

Open on UPC Registry